Log In
BCIQ
Print this Print this
 

hsa-miR-31-5p

  Manage Alerts
Collapse Summary General Information
Company TAmiRNA GmbH
DescriptionMicroRNA-31 (mIR-31) inhibitor
Molecular Target MicroRNA-31 (miR-31)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: microRNA
Latest Stage of DevelopmentDiscovery
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today